Showing results (471-480 of 10,340) with videos related to
Sort By:
Pageof 1,034
Annals of the Rheumatic Diseases|August 19, 2021
Very low prevalence of ultrasound-detected tenosynovial abnormalities in healthy subjects throughout the age range: OMERACT ultrasound minimal disease studyJeanette Trickey, Ilfita Sahbudin, Mads Ammitzbøll-Danielsen, et al.Annals of the Rheumatic Diseases|August 3, 2022
Distinct immune-effector and metabolic profile of CD8+ T cells in patients with autoimmune polyarthritis induced by therapy with immune checkpoint inhibitorsKarolina Benesova, Franziska Viktoria Kraus, Rui A Carvalho, et al.Annals of the Rheumatic Diseases|May 16, 2020
TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitinationGangliang Wang, Shuai Chen, Ziang Xie, et al.Annals of the Rheumatic Diseases|May 1, 2020
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient managementMarco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, et al.Annals of the Rheumatic Diseases|May 7, 2020
Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumabInbal Haya Shafran, Farideh Alasti, Josef S Smolen, et al.Annals of the Rheumatic Diseases|May 7, 2020
Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteriaWalter P Maksymowych, Susanne Juhl Pedersen, Ulrich Weber, et al.Annals of the Rheumatic Diseases|April 28, 2021
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled studyAtul Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, et al.Annals of the Rheumatic Diseases|June 12, 2020
MRI of sacroiliac joints for the diagnosis of axial SpA: prevalence of inflammatory and structural lesions in nulliparous, early postpartum and late postpartum womenAdel Hoballah, Cédric Lukas, Christophe Leplat, et al.Annals of the Rheumatic Diseases|November 10, 2022
Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunitiesAlvise Berti, Fabiola Atzeni, Lorenzo Dagna, et al.Annals of the Rheumatic Diseases|November 10, 2022
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseasesEileen W Stalman, Luuk Wieske, Koos P J van Dam, et al.Pageof 1,034